Tue.Mar 25, 2025

article thumbnail

Opinion: 23andMe’s bankruptcy doesn’t diminish its impact

STAT

23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.

326
326
article thumbnail

Is my Pharma Marketing Job Going to Be Eliminated?

Pharma Marketing Network

Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Become a Medical Affairs Specialist [Career Path Guide]

The Happy PharmD

Pharmacists who want to break into medical affairs often feel stuck. They know they want a change, but theyre unsure how to make the transitionespecially when they have zero industry experience. But heres the thing: you dont need to start over. You dont need another degree. And you dont need years of industry work under your belt. Vincent had the same doubts.

article thumbnail

STAT+: Oz moves closer to role running Medicare, Medicaid on party-line vote

STAT

Mehmet Oz has been a heart surgeon, a TV show host, an author, and a Senate candidate. On Tuesday, he inched closer to adding CMS administrator to the list.  The Senate Finance Committee voted along party lines to send Oz’s nomination to lead the Centers for Medicare and Medicaid Services to the full Senate for a vote, where he’ll likely be confirmed.

Hospitals 313
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

UK downgrades mpox from ‘high consequence infectious disease’ status

The Pharmacist

Clade Ia and Ib mpox has been downgraded from a high consequence infectious disease in the UK, public health officials have confirmed. A review by the Advisory Committee on Dangerous Pathogens found that clade I mpox no longer meets the criteria as a high consequence infectious disease defined as having a high mortality rate and […] The post UK downgrades mpox from high consequence infectious disease status appeared first on The Pharmacist.

40
article thumbnail

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

Express Pharma

The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of 44 per cent, with sales projected to rise from $8.70 billion in 2024 to $76.03 billion in 2030. Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData, a leading data and analytics company.

More Trending

article thumbnail

Stanford professor Jay Bhattacharya confirmed by Senate to run NIH

STAT

WASHINGTON — The Senate voted along party lines to confirm Stanford professor Jay Bhattacharya as director of the National Institutes of Health, the biggest funder of biomedical research in the world.  The vote was 53-47, with all Republicans backing Bhattacharya. It’s the conclusion to a relatively smooth confirmation process for Bhattacharya, who echoed health secretary Robert F.

article thumbnail

Cadila Pharma launches Cadilose, a lactulose solution for constipation and hepatic encephalopathy

Express Pharma

Cadila Pharmaceuticals has launched Cadilose, an advanced Lactulose formulation designed to effectively manage constipation and hepatic encephalopathy (HE). Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the intestines and promotes smooth bowel movements. It also functions as a prebiotic, encouraging the growth of beneficial gut bacteria.

59
article thumbnail

How to Reach HCP’s In Pharma Marketing

Pharma Marketing Network

Healthcare professionals (HCPs) are the cornerstone of pharmaceutical success, yet reaching them has never been more complex. Between digital saturation, regulatory scrutiny, and shifting engagement preferences, marketers must be both strategic and adaptable. Understanding how to effectively engage HCPs in pharma marketing is essential for driving brand awareness, product education, and ultimately, prescription behavior.

52
article thumbnail

Medical Device Notification Warns of Continued Data Integrity Concerns

FDA Law Blog: Biosimilars

By Adrienne R. Lenz, Principal Medical Device Regulation Expert Last year, FDA issued a letter to the medical device industry warning medical device firms of concerns related to fraudulent and unreliable laboratory testing data in premarket submissions, which we blogged about here. This was followed last September with warning letters issued to two Chinese firms performing biocompatibility testing, citing violations of 21 C.F.R.

59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

MSD to advance investigational Lp(a) inhibitor in nearly $2b deal

European Pharmaceutical Review

MSD (Merck) has gained global rights to develop, manufacture and commercialise an oral small molecule Lipoprotein(a) inhibitor, currently being investigated in a Phase II clinical trial for atherosclerosis.Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma) has agreed to license its drug candidate HRS-5346 worldwide, excluding the Greater China region.As part of the agreement, MSD will give Hengrui Pharma an initial sum of $200 million in exchange for rights to its Lp(a) inhibitor.

article thumbnail

STAT+: Health insurers’ rapid adoption of AI tools is outpacing regulators’ ability to keep watch

STAT

Inside the nation’s largest health insurance companies, artificial intelligence is taking off like a rocket. Elevance, which covers about 110 million people, has rolled out a generative AI model to 50,000 employees. Centene Corp, which serves more than 28 million people, is using it to manage contracts with medical groups and measure their performance.

article thumbnail

Biogen plots new global headquarters in Kendall Square

PharmaVoice

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

130
130
article thumbnail

How health insurers are using AI today

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. How insurers use AI Executives of the nation’s largest health insurance companies regularly highlight their use of AI tools in earnings calls and meetings with investors.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA starts review of Sanofi's MS hope tolebrutinib

pharmaphorum

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis

101
101
article thumbnail

Does the kidney transplant system need to change?

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! It was quite a rainy day in Boston yesterday — but at least it wasn’t a cold one. I’m manifesting some sun for today.

237
237
article thumbnail

GSK and UK researchers plan to study Shingrix and dementia risk reduction link

Pharmaceutical Technology

The study will analyse electronic health records of 65- and 66-year olds from the UKs National Health Service (NHS).

90
article thumbnail

Merck bets $200M on a new type of heart pill

BioPharma Dive

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a genetic risk factor called lipoprotein(a).

85
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

UK weight loss market: M&A opportunities

pharmaphorum

Explore the latest M&A opportunities in the UK weight loss market, including market access for products like Wegovy and Mounjaro. Stay informed about key trends and opportunities in the industry.

66
article thumbnail

Character Biosciences raises $93M with an eye on vision loss drugs

BioPharma Dive

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed geographic atrophy medicines.

78
article thumbnail

AbbVie sues Genmab, claiming trade secrets theft

pharmaphorum

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets

66
article thumbnail

New tool to boost cancer immunotherapy effects

World Pharma News

Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot overcome the tumours defense mechanism and the cancer grows. Now, a study published in Nature Immunology, with the involvement of the Hospital del Mar Research Institute, the Universitat Autnoma de Barcelona and the Pompeu Fabra University, proposes a new approach to strengthen NK cells in their fight a

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Educate Patients About How PBMs’ Vertical Integration Impacts Their Health Care

Pharmacy Times

Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicatedand often leaves patients footing the bill.

59
article thumbnail

MSD licenses Lp(a) heart drug from Hengrui in $2bn deal

pharmaphorum

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront

59
article thumbnail

Examining Healthcare Spending Across US Counties

Pharmaceutical Commerce

What drivers impact the differences in expenditures?

59
article thumbnail

WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions

Pharmaceutical Technology

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharma Pulse 3/25/25: Identifying Affordability Issues with Predictive Analytics, Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

59
article thumbnail

First Antibody Therapy for Acute Myocardial Infarction Granted FDA Fast Track Designation

Pharmacy Times

If approved, this novel monoclonal antibody therapy could become a standard of care emergency option for patients with acute myocardial infarction, which affects millions in the United States and across the world.

52
article thumbnail

5 ways to address pricing and access challenges across the European landscape

pharmaphorum

EVERSANA discuss 5 effective strategies for overcoming pricing and access challenges in the European healthcare landscape. Learn about HTA, risk-sharing, data utilisation, orphan drugs, and more.

52
article thumbnail

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

PharmaTech

Under the agreement, AstraZeneca will use Alteogens proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.